Long-term consumption of high-protein (HP) diets at 35% of energy is postulated to negatively influence bone health.
Introduction
Since the implementation of the dietary reference intakes, protein has been expressed in terms of the acceptable macronutrient distribution range (AMDR), 6 defined as the level at which the consumption of a specific source of energy provides an acceptable nutrient value while concurrently reducing incidence of disease (1) . For protein, the lower and upper AMDR ranges for adults are currently set at 10 and 35%, respectively (2) . There is presently limited experimental affirmation to deem the 35% upper limit AMDR for protein as safe with respect to longterm human health (2) . Because high-protein (HP) diets at or above AMDR are widely utilized as a means for weight loss and control (3) , this lack of evidence is particularly worrisome (4) .
Excessive protein consumption may deleteriously affect renal (5) and bone health (6, 7) . Acting as a buffer system, bone aids in the modulation of acid-base homeostasis (8) through the release of calcium (9) . In theory, elevated protein consumption is acidogenic (6) , resulting in increased bone resorption (10) . An observational study in women suggests that HP diets are associated with higher bone resorption (11) , while 2 others suggest that HP diets of animal sources resulted in higher risk of fracture of the forearm (12) or hip fracture (13) . This was confirmed by observations in healthy rats (14, 15) . Conversely, other HP studies in both healthy rodents (9, 16, 17) and elderly adults (18) did not show a negative relationship, highlighting the uncertainty surrounding the effect of HP consumption on bone.
To fully understand the effect of high protein intakes on bone, it is necessary to comprehensively investigate the physiological, anthropometrical, biochemical, and biomechanical parameters of bone during short-to long-term HP consumption. Because many protein sources such as milk powder are rich in calcium, it is important to control for dietary calcium intakes. Therefore, it was the purpose of this study to comprehensively examine the effect of long-term elevated protein consumption at the current AMDR upper range of 35% on bone and body composition. This research represents an arm of a larger study designed to address renal and bone consequences of a high protein diet in Sprague-Dawley rats, a rodent strain appropriate for such analyses (19) .
Methods and Materials
Animals and experimental design. Eighty female Sprague-Dawley rats (University of Manitoba) were randomized to receive 4, 8, 12, or 17 mo of a normal-protein (NP) control (15% AMDR) or HP (35% AMDR) diet. Rats consumed all diets ad libitum, commencing at 70 d to initiate dietary consumption at sexual maturity but prior to achievement of peak bone mass ( Table 1) . These time points were chosen to represent physiological periods of importance to bone health in females: acquisition of peak bone mass (baseline to mo 4), maintenance of bone and just prior to natural menopause (mo 8), early postmenopause (mo 12), and advanced aging (mo 17). The diets were based on the AIN-93 diet for maintenance (20) with changes made to macronutrient values to accommodate the HP diet. All micronutrients were standardized between the 2 diets, matching the nutrient requirements for rat growth and maintenance (21) . To simulate a representative mixed HP diet typical of humans, the protein composition contained one-third plantand two-thirds animal-based protein sources (22) . Rats were fed and housed in pairs and weight was measured at baseline, weekly for the entirety of the study, and at termination. During the last week of study prior to the 4, 8, and 12 mo time points, blood was collected between 0800 and 1000 from the saphenous vein to obtain serum that was stored at -808C until analysis. Rats then underwent a 3-d metabolic balance for measuring food intake followed by dual-energy X-ray absorptiometry (DXA) scanning to measure body composition, bone mass, and then necropsy. Due to the large size of the rats at 17 mo relative to the metabolic cages, the 3-d metabolic balance for food intake was not conducted. Following necropsy, femurs and tibias were excised, cleaned, wrapped in saline-soaked gauze, and stored at 2808C. After the completion of the study, all samples were shipped on dry ice from the University of Manitoba to McGill University for analysis. All procedures were reviewed and approved by the University of Manitoba Animal Care Committee and in accordance with the Canadian Council on Animal Care Guidelines (23) .
Whole body composition and osseous mineralization analysis. Rats were scanned in the anesthetized state using isoflurane gas (Baxter International) at their respective month using DXA (Hologic 4500A QDR version 11.2, Hologic). Measurements of body weight, body fat (BF), and lean body mass (LBM) were made using small animal software. To examine if the effect of the HP diet on BF was generalized or confined to a specific region, abdominal fat mass was measured as a proxy for visceral fat (24, 25) and defined as the region from just below the last rib to the top of the iliac crest of the pelvic region. We also measured bone mineral content (BMC) and density (BMD) using the small animal software for whole body and high resolution regional scans (right femora, tibia, and the lumbar vertebrae 1-4). Data were expressed as absolute values and BMC was expressed relative to body weight (g/kg).
Ionized calcium and phosphorus concentrations as well as pH were measured in serum using a Nova analyzer (Model 11, Nova Biomedical; CV ,1.6%). To quantify bone formation and bone resorption, serum concentrations of both osteocalcin (Metra Osteocalcin, Quidel; CV = 6.8%) and carboxy-terminal crosslinks of type I collagen (CTX) (Ratlaps, Nordic Bioscience Diagnostics; CV = 8.2%) were quantified using rat-specific ELISA.
Insulin-like growth factor 1 (IGF-1), leptin, and adiponectin were measured as they relate to bone and body composition. Serum leptin (SPI BIO Leptin, Cayman Chemical; CV = 4.8%) and adiponectin (ALPCO Diagnostics; CV = 3.1%) were assessed using specific enzyme immunoassays while serum IGF-1 (IDS; CV = 3.2%) was measured with a ratspecific ELISA.
Bone microarchitecture analysis. Microcomputerized tomography (mCT) was used at the 17-mo time point to assess the microarchitecture of the left femora of rats fed either of the 2 diets. A total of 17 femurs (NP: n = 7; HP: n = 10) were measured at the Center for Bone and Periodontal Research at McGill University (Montreal, Canada) using a small rodent mCT (Skyscan version 1072, SKYSCAN). To standardize settings for all bones, a source of 80 kV and 124 mA, a 0.5-mm filter, a 253 zoom, a 11.25-mm pixel size, a time of 7.5 s, and a rotation of 0.9 were used. All femurs were analyzed just under the femoral neck and assessed for trabecular measurements using the Skyscan 'shrink wrap' option to define bone contours and internal porosity.
Bone biomechanical analysis. Prior to biomechanical testing, all femurs and tibias were measured using a digital caliper for total length, mid-diaphysis, and 1/3 proximal diaphysis (26) . Bone strength was assessed in right femurs and tibias using the 3-point flexure method at the mid-diaphysis (Instron version 5544). Bones were warmed to 378C for 5 min in a saline bath to mimic physiological conditions (27) then mounted on the jig with a base span of 14 mm for femurs and 12 mm for tibias. For right femurs, a 5N load was applied at a preloading rate of 15 mm/min until contact with the mid-diaphysis, at which point the rate continued at 1 mm/min (28) . Left femurs underwent similar 3-point flexure testing but were broken at the proximal 1/3 diaphysis point to represent a higher cancellous:cortical ratio. Measurements for flexure load at yield and load at break were obtained. Flexure load at yield (n) is defined as the corresponding load at the point in which permanent bone deformation instigates (29) . Load at break (n), also referred to as the ultimate strength, is the final force recorded at the ultimate fracture (29) . As the femoral neck is the bone site with the highest incidence of fracture (30) , previously broken right femora were tested for femoral neck strength to represent a loading-based fracture (31) . The femoral diaphysis was potted in dental resin and after 40 min mounted on the base of the Instron. A breaking rate of 0.5 mm/min was applied to the medial region of the femoral head as previously described (30) . Following biomechan- (20) . 2 Dicalcium phosphate (0.9 g/100 g), potassium chloride (0.6 g/100 g), and sodium chloride (0.6 g/100 g) were added to the NP diet. 3 Sodium phosphate monobasic (0.07 g/100 g) and dicalcium phosphate (0.2 g/100 g), potassium chloride (0.2 g/100 g), and sodium chloride (0.2 g/100 g) were added to the HP diet to balance Ca, P, K, and Na levels.
ical testing, mid-diaphysis cancellous (outer to the inner endosteum) and cortical (outer to the inner periosteum) diameters were measured using the caliper at the break site.
Statistical methods. The sample size was calculated as 8 rats per group to detect a 10% change in femoral BMC with a = 0.05 and a power = 0.80. The number of rats per group studied was 10 per group to account for unrelated morbidity over the long-term study. Differences between the diet groups were tested using diet and time (4, 8, 12 , or 17 mo) as fixed effects in a 2-way factorial ANOVA including diet 3 time interactions (SAS version 9.1). Because there were only 2 diets, post hoc testing was not required. Post hoc testing for significant effects of time or diet 3 time interactions (indicated where applicable) were assessed using the all pairwise Bonferroni's test with a P , 0.05. As mCT was only performed at mo 17, measurements were assessed using a t test with a P , 0.05. Normality was assessed using the Kolmogorov-Smirnov test and equal variances examined using the Levene test. Data that failed assumptions for normality were transformed prior to ANOVA testing; square root was used for tibia BMC and BMC/kg and log was used for lean and fat mass. All results are expressed as mean 6 SD.
Results
Food intake and growth. Although food intake relative to body weight did not differ by diet (NP, 38.4 6 9.4; HP, 37.4 6 7.7 g/kg; P = 0.61), rats at 12 mo (32.6 6 8.8 g/kg) had lower intakes than at 4 (40.9 6 5.9 g/kg; P = 0.005) and 8 mo (40.3 6 8.2 g/kg; P = 0.009). Overall, HP rats had~10% lower whole body weight than their NP-fed counterparts (P = 0.006; Table 2 ) despite no differences in body or tail length. Although rats increased in body weight (P # 0.0001), length (P = 0.01), and tail length over time (P # 0.0001; Table 2 ), there were no interactions with diet.
Body
data not shown). Similarly, HP rats had a greater absolute LBM (P # 0.0001) and the content increased over time (P = 0.05) ( Table 2) . At both the whole body and regional level at all ages, HP rats had~29% less fat content than NP-fed rats and fat content increased over time (P # 0.0001).
HP rats had~7% less whole body BMC (12.7 6 2.6 g) than NP-fed rats (13.6 6 2.1 g; P = 0.03) but not following adjustment for weight (NP, 31.4 6 2.9; HP, 31.7 g/kg; P = 0.54). Similarly, diet did not affect whole body BMD (g/cm 2 ; data not shown). All of these variables consistently increased over time (P = 0.0004, P # 0.0001, P = 0.005; data not shown).
Although not in regional measurements of BMC, HP increased weight-adjusted BMC in the femur (P = 0.002), tibia (P = 0.009), and lumbar vertebra (P = 0.02) ( Table 3 ). All variables were affected by time. Time, but not diet, affected BMD in the femur (P # 0.0001) and lumbar vertebra (P = 0.002). In the tibia, BMD was affected by an interaction between diet and time (P = 0.046), although post hoc analysis did not reveal differences among the groups across time (Table 3) .
Serum biochemistry. Diet did not affect calcium, phosphorus, or blood pH. Phosphorus decreased (mo 4, 2.2 6 0.1; mo 8, 1.9 6 0.3; mo 12, 1.8 6 0.2 mmol/L; P = 0.001) and pH increased (mo 4, 7.49 6 0.05; mo 8, 7.47 6 0.05; mo 12, 7.57 6 0.06; P # 0.001) over time but there were no diet 3 time interactions affecting these variables.
The serum leptin concentration was~35% lower in rats that consumed the HP diet (0.9 6 0.7 nmol/L) compared with those that consumed the NP diet (1.4 6 0.8 nmol/L; P = 0.003; 1 Data are mean 6 SD, n = 10 except n = 7 for NP at mo 17. For all rats, means without a common letter differ, P , 0.05.
Supplemental Table 1 ). Rats at mo 12 (1.7 6 1.0 nmol/L) had higher leptin concentrations than at mo 4 (0.9 6 0.4 nmol/L; P = 0.003) and mo 8 (1.0 6 0.5 nmol/L; P = 0.009). Serum adiponectin concentrations in rats fed the HP diet (0.13 6 0.05 mmol/L) were~33% lower than in NP-fed rats (0.19 6 0.06 mmol/L; P # 0.0001). However, HP consumption did not alter concentrations of IGF-1. Serum concentrations of adiponectin or IGF-1 did not change over time. Diet did not alter the bone biomarkers osteocalcin and CTX (Supplemental Table 1 ). Unlike osteocalcin, concentrations of CTX decreased over time in both dietary groups (P = 0.003).
Biomechanical testing. Diet did not alter any femoral or tibia biomechanical parameters at mid-diaphysis, whereas time significantly affected femoral load at break (Table 4) . Similarly, diet did not affect any of the biomechanical parameters at the femoral head or 1/3 diaphysis (data not shown). There were no interactions noted in any of the parameters measured. Rats fed the HP diet had lower tibia cortical diameters (0.75 6 0.08 mm) compared with those fed the NP diet (0.80 6 0.07 mm; P = 0.006), but this variable did not change over time.
mCT analysis. Femurs from the 17 mo time point were analyzed for trabecular, whole, and interpolated cortical bone specifics. The dietary intervention did not affect any of the parameters measured at both the trabecular and whole bone ( Table 5 ). An image of this analysis can be viewed in Supplemental Figure 1 .
Discussion
Attributable to growing concern, a thorough understanding of the physiological outcomes of long-term HP consumption on the renal system and bone remains a fundamental goal in setting safe dietary recommendations. The aim of this study was to examine The effectiveness of HP diets as a means of weight and fat reduction has been demonstrated in previous studies (4) . As was anticipated, rat fed HP diets had lower measurements for body weight and fat mass in addition to higher LBM. Given that BMI and fat mass are inversely related to bone resorption (32) and positively related to bone mass (33, 34) , they are regarded as a safeguard for bone (35) . While in this study the HP diet resulted in lower whole body BMC, areas susceptible to fracture maintained BMC and BMD. Similarly, Mardon et al. (9) observed no reduction in femoral BMD following 21 mo of 26% HP diet in rats. Furthermore, femur, tibia, and spine BMC were 10-13% higher in HP-fed rats when adjusted for body weight. This suggests that even though fat mass following the HP diet was lower, there was no compromise to bone. This is further confirmed by no difference between groups in the bone turnover markers and bone strength testing.
It has been postulated that HP consumption coupled with adequate calcium intakes attenuate losses of mineral from bone (36) . In this study, HP and NP diets were equal in calcium (0.50%) and phosphorus (0.3%) content at recommended amounts (21) . Two human trials of HP diets combined with adequate calcium through dairy products demonstrate protection against bone resorption (37) and bone loss despite elevated urinary calcium (36) . The hypercalciuria likely reflects increased intestinal calcium absorption rather than bone resorption as demonstrated in a 10-d study of HP diets in women (38) . In our study, bone formation, resorption, BMD, and mCT data indicated no significant differences between the dietary groups. Collectively, these findings suggest that when provided with adequate or high calcium intakes, bone loss ascribed to high protein consumption may be lessened.
Higher BW can improve bone quality through biomechanical loading, in addition to the release of vital fat-related hormones that effect bone (39) . As an adipocyte-secreted hormone, leptin aids in the maintenance of body weight (40) and appetite (32) . Leptin also modulates bone turnover (41) by inhibiting bone formation (34) . Similarly, another adipose-derived hormone, adiponectin, typically is inversely associated with BMD (42) and bone mass (43) . Although HP-fed rats in this study had lower leptin and adiponectin in agreement with lower fat mass, BMD was not altered. Because this is, to the authors' knowledge, one of the first HP analyses to measure both adipose hormones, further analyses are required to better understand this lack of association with bone.
As a known bone-promoting factor (35) , production of IGF-1 is in turn stimulated by the consumption of protein (44) . Low protein intake can significantly reduce circulating IGF-1, resulting in a possible detriment to bone (45) . In this study, IGF-1 was unaffected by HP consumption, matching the lack of variability noted in measurements for BMD. This agrees with Mardon et al. (9) , who suggest that such unaltered IGF-1 concentrations in their analysis result from the unrestricted nature of the diets. A similar argument could be made for this study. Although HP diets are acidogenic (6), those derived primarily from animal sources are more acidogenic than mixed diets due to a high ratio of acid precursors, which could negatively impact bone (13, 46) . In rats, urinary pH inversely relates to urine calcium concentration (9, 17) . Our HP diet did not lower serum pH, nor was there a change in serum calcium and phosphorus. The HP diet was mainly comprised of mixed protein sources to mimic that commonly consumed by humans (22) . In keeping with this study, several human-based mixed HP analyses have concluded no detrimental effect to bone (47, 48) as opposed to HP diets based on animal protein (12, 13) .
Densitometry alone provides very limited indication of total bone stiffness, a measurement required to comprehend the fragility of the bone (27) . Few studies of HP diets have incorporated this technique (9, 15, 49) . To the authors' knowledge, this study is the first within this realm of research to perform tests at the mid and proximal diaphysis plus femoral head region. Consistent with results from DXA and bone turnover analyses, HP consumption neither improved nor hindered bone stability at any of these sites that represent different cancellous:cortical ratios. Aside from the slight tendency for lower BMD in tibias, no other assessments were altered. Thus, tibia integrity was not significantly altered by HP consumption.
This study did present several limitations. Measurements for food intake and serum pH, calcium, and phosphorus were not obtained at mo 17 for practical reasons. The mCT measurements for mo 4, 8, and 12 were also unavailable. Additionally, only a sample size of 7 was available for a dietary group in the mo 17 analysis. Although this is below the estimated sample size of 8 per group, the reported results consistently indicate a lack of dietary effect on bone using 3 standard measurements for bone: DXA, mCT, and bone strength.
Previously, research investigating the effect of an elevated protein diet at 35% AMDR upper limit on bone was inconsistent. Because the adoption of HP diets for weight loss and maintenance has become increasingly popular over the past decades, it is crucial that researchers set standards of protein that are safe for public consumption. In this study, sexually mature female Sprague-Dawley rats were randomized to receive either a normal 15% or a high 35% of energy mixed protein diet throughout their adult lifespan. The high mixed protein consumption was associated with reduced weight, fat mass, and higher LBM, but no deleterious effects to bone. Therefore, it can be concluded that a mixed HP diet containing adequate calcium levels at the current upper 35% of energy can be deemed safe in respect to long-term bone health in rats.
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